# Stem Cell Derived Exome for Treatment of Diabetic Foot

> **NCT06480123** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Diabetic Foot
- Stem Cell

## Interventions

- **DRUG:** Skin drug prepared with exome originated from stem cell

## Key facts

- **NCT ID:** NCT06480123
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2028-12-30
- **Final completion:** 2033-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06480123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06480123, "Stem Cell Derived Exome for Treatment of Diabetic Foot". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06480123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*